Table 2.

Effects of Behavioral Health Home Enrollment on Quality of Cardiovascular Care

Quality of care measures	Odds ratio (95% CI)	Predicted probability of receiving guideline-concordant care, per year (95% CI)
		Health home group	Comparison group
Population with diabetes
Annual receipt of:
Diabetic eye exam	1.86 (1.19–2.91)*	0.98 (0.97–0.99)	0.96 (0.96–0.97)
Diabetic foot exam	1.46 (0.92–2.31)	0.02 (0.01–0.03)	0.01 (0.01–0.02)
Hemoglobin A1c test	1.06 (0.91–1.23)	0.54 (0.51–0.57)	0.53 (0.51–0.55)
Diabetic nephrology test	1.03 (0.89–1.19)	0.59 (0.56–0.62)	0.58 (0.56–0.60)
Cholesterol test	1.02 (0.88–1.19)	0.48 (0.44–0.51)	0.47 (0.45–0.49)
Any statin therapy	0.88 (0.65–1.19)	0.32 (0.26–0.38)	0.35 (0.31–0.39)
> 80% statin therapy adherence	1.26 (0.91–1.75)	0.24 (0.19–0.29)	0.20 (0.17–0.23)
Population with cardiovascular disease
Annual receipt of:
Cardiovascular monitoring	1.00 (0.84–1.20)	0.45 (0.41–0.49)	0.45 (0.43–0.47)
Any statin therapy	1.20 (0.87–1.67)	0.26 (0.20–0.31)	0.23 (0.20–0.25)
> 80% statin therapy adherence	1.08 (0.77–1.53)	0.15 (0.11–0.19)	0.14 (0.12–0.16)

*p < 0.05